Stephan Bernstein, CEO of GreenRoc, details the PFS results for the new graphite processing plant. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSupply@me Cap Regulatory News (SYME)

Share Price Information for Supply@me Cap (SYME)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 0.022
Bid: 0.021
Ask: 0.023
Change: -0.0005 (-2.22%)
Spread: 0.002 (9.524%)
Open: 0.02
High: 0.023
Low: 0.02
Prev. Close: 0.0225
SYME Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Transfer of Warrants

28 Mar 2024 07:00

RNS Number : 6025I
Supply@ME Capital PLC
28 March 2024
 

28 March 2024

Supply@ME Capital plc (the "Company" or "SYME")

Transfer of Warrants

SYME, the fintech business which provides an innovative fintech platform (the "Platform") for use by manufacturing and trading companies to access Inventory Monetisation© ("IM") solutions enabling their businesses to generate cashflow, today announces an update in relation to the entire holding of 961,832,433 warrants (each exercisable into one new ordinary share of nominal value £0.00002 each in the capital of the Company) in aggregate (the "Warrants") previously issued to of Mercator Capital Management Fund LP ("Mercator") pursuant to seven warrant instruments executed by the Company, cast as deed polls, between 1 October 2021 and 14 July 2022 (the "Warrant Instruments").

The Company previously announced on 23 November 2023 that the entire holding of 961,832,433 have been sold and transferred by Mercator to an independent third party purchaser (the "Current Warrant Holder"). Today, the Company further announces that the Current Warrant Holder has sold and transferred (the "Transfer") the entire holding of the Warrants to two separate third party purchasers (the "Transferees").

A summary of the key terms of the Warrants are set out in the table below:

Date of issue

Maturity date

Number of Warrants

Exercise price

01/10/2021

01/10/2024

443,726,031

£0.00316

01/11/2021

01/11/2024

29,197,856

£0.00314

01/12/2021

01/12/2024

49,867,625

£0.00184

04/01/2022

04/01/2025

77,763,767

£0.00174

02/02/2022

02/02/2025

79,179,799

£0.00171

04/03/2022

04/03/2025

105,948,198

£0.00128

14/07/2022

14/07/2025

176,149,157

£0.00085

Total

 

961,832,433

 

 

The Company has confirmed that the Transferees are neither an affiliate of the Current Warrant Holder, nor a person closely associated of any person discharging managerial responsibilities of the Company for the purposes of Regulation 2014/596/EU, which is part of the domestic law of the United Kingdom of Great Britain and Northern Ireland pursuant to the Market Abuse (Amendment) (EU Exit) Regulations (SI 2019/310)).

Under the terms of the Warrant Instruments, the Warrants may only be transferred to affiliates of the holder of the Warrants from time to time. The Company authorised the Transfer in accordance with the modification provisions in the Warrant Instruments on this occasion, but, going forwards, the terms of the Warrant Instruments shall continue to preclude transfer to non-affiliates of the holder of the Warrants without the consent of the Company. The new certificates in respect of the Warrants will be sent to the Transferee shortly.

Contact information:

Alessandro Zamboni, CEO, Supply@ME Capital plc, investors@supplymecapital.com

Notes:

SYME and its operating subsidiaries provide its Platform for use by manufacturing and trading companies to access inventory trade solutions enabling their businesses to generate cashflow, via a non-credit approach and without incurring debt. This is achieved by their existing eligible inventory being added to the Platform and then monetised via purchase by third party Inventory Funders. The inventory to be monetised can include warehouse goods waiting to be sold to end-customers or goods/commodities that are part of a typical import/export transaction.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DSHDZGZFGNRGDZZ
Date   Source Headline
29th Sep 20227:00 amRNS2022 Interim Results
22nd Sep 20227:00 amRNSExercise of Warrants, Issue of Equity and TVR
14th Sep 20227:00 amRNSExercise of Warrants, Issue of Equity and TVR
13th Sep 20227:00 amRNSHolding in Company
12th Sep 20227:00 amRNSInaugural IM transaction executed
6th Sep 20222:00 pmRNSPrice Monitoring Extension
5th Sep 202211:05 amRNSSecond Price Monitoring Extn
5th Sep 202211:00 amRNSPrice Monitoring Extension
5th Sep 20227:00 amRNSIssue of Equity & Total Voting Rights
31st Aug 20227:00 amRNSIssue of Equity & Total Voting Rights
30th Aug 20227:12 amRNSHolding in Company
23rd Aug 20224:40 pmRNSSecond Price Monitoring Extn
23rd Aug 20224:35 pmRNSPrice Monitoring Extension
18th Aug 20227:00 amRNSResult of Open Offer
17th Aug 202211:05 amRNSPDMR/PCA Shareholding: Stock Loans Updates
15th Aug 20224:41 pmRNSSecond Price Monitoring Extn
15th Aug 20224:36 pmRNSPrice Monitoring Extension
10th Aug 20224:41 pmRNSSecond Price Monitoring Extn
10th Aug 20224:35 pmRNSPrice Monitoring Extension
9th Aug 20227:00 amRNSFirst IM Transaction: Binding commitment signed
8th Aug 20222:00 pmRNSPrice Monitoring Extension
1st Aug 20225:15 pmRNSTotal Voting Rights
1st Aug 20228:00 amRNSHolding in Company
29th Jul 20224:41 pmRNSSecond Price Monitoring Extn
29th Jul 20224:36 pmRNSPrice Monitoring Extension
29th Jul 20227:00 amRNSUpdate on first Inventory Monetisation Transaction
25th Jul 20227:00 amRNSDirectors/PDMR Shareholding
22nd Jul 20227:00 amRNSOpen Offer & Business Update
18th Jul 20221:13 pmRNSThird tranche of shares issued to Venus Capital
30th Jun 20224:29 pmRNSResult of AGM
28th Jun 20227:00 amRNSStrategic Alliance with VeChain Foundation
23rd Jun 20227:00 amRNSTradeflow and DP World complete first transaction
14th Jun 20227:00 amRNSNotice of AGM: CORRECTION
13th Jun 20227:00 amRNSAppointment of Independent Non-Executive Director
10th Jun 20227:00 amRNSNotice of AGM
6th Jun 20224:17 pmRNSPosting of 2021 Annual Report & Notice of AGM
6th Jun 20227:00 amRNSAppointment of new independent Non-Executive Chair
31st May 20227:00 amRNS2021 Annual Financial Report
25th May 20223:01 pmRNSTotal Voting Rights
10th May 20224:38 pmRNSSecond tranche of shares issued to Venus Capital
10th May 20227:00 amRNSSecond tranche of shares issued to Venus Capital
3rd May 20229:06 amRNSSecond Price Monitoring Extn
3rd May 20229:00 amRNSPrice Monitoring Extension
27th Apr 20222:06 pmRNSSecond Price Monitoring Extn
27th Apr 20222:00 pmRNSPrice Monitoring Extension
27th Apr 202211:05 amRNSSecond Price Monitoring Extn
27th Apr 202211:00 amRNSPrice Monitoring Extension
27th Apr 20229:05 amRNSSecond Price Monitoring Extn
27th Apr 20229:00 amRNSPrice Monitoring Extension
27th Apr 20227:01 amRNSCapital Enhancement Plan & Revised Date of Results

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.